Non-Amyloid Approaches to Disease Modification for Alzheimer’s Disease: An EU/US CTAD Task Force Report

While amyloid-targeting therapies continue to predominate in the Alzheimer’s disease (AD) drug development pipeline, there is increasing recognition that to effectively treat the disease it may be necessary to target other mechanisms and pathways as well. In December 2019, The EU/US CTAD Task Force...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Prev Alzheimers Dis
Main Authors: Gauthier, Serge, Aisen, P. S., Cummings, J., Detke, M. J., Longo, F. M., Raman, R., Sabbagh, M., Schneider, L., Tanzi, R., Tariot, P., Weiner, M., Touchon, J., Vellas, B.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2020
Assuntos:
CTAD Task Force Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7223540/
https://ncbi.nlm.nih.gov/pubmed/32420298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14283/jpad.2020.18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados